Compounds > doripenem
Page last updated: 2024-08-25

doripenem and Cronobacter Infections

doripenem has been researched along with Cronobacter Infections in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY1
Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE1
Bell, JM; Mendes, RE; Rhomberg, PR; Sader, HS; Turnidge, JD1
Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Picazo, JJ; Rodríguez-Avial, I1
Cantón, R; García, A; Gimeno, C; Gobernado, M1
Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G1

Other Studies

6 other study(ies) available for doripenem and Cronobacter Infections

ArticleYear
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence

2010
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests

2014
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests

2009
Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2010
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:3

    Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas Infections; Spain; Thienamycins

2010
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins

2012